Question 1

What is the analyst consensus rating for EVMN?

Accepted Answer

The analyst consensus rating for EVMN is "Buy" based on 8 analyst recommendations.

Question 2

What is the average price target for EVMN?

Accepted Answer

The average 12-month price target for EVMN is $39.17, representing an upside of 25.5% from the current price of $31.20.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jan 22, 2026	Andreas Argyrides	Oppenheimer	Initiates	Buy	$42.00
Jan 8, 2026	Martin Auster	Raymond James	Initiates	Strong Buy	$40.00
Jan 6, 2026	Mitchell S. Kapoor	HC Wainwright	Initiates	Strong Buy	$35.00
Dec 1, 2025	Prakhar Agrawal	Cantor Fitzgerald	Initiates	Buy	-
Dec 1, 2025	Matt Phipps	William Blair	Initiates	Buy	-
Dec 1, 2025	Thomas Smith	Leerink Partners	Initiates	Buy	$42.00
Dec 1, 2025	Gavin Clark-Gartner	Evercore ISI Group	Initiates	Buy	$40.00
Dec 1, 2025	Judah Frommer	Morgan Stanley	Initiates	Buy	$36.00

Evommune (EVMN) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest EVMN Analyst Ratings & Recommendations